Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer

Clinical trial NCT05869097 · COMPLETED

Trial details

NCT number: NCT05869097
Sponsor: Hunan Cancer Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Colorectal Adenocarcinoma

Start date: 2020-11-01
Primary completion: 2022-10-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.